India·Source-based summary
Study attempts to find out howIndia made expensive diabetes medicines affordable
India’s low medication prices are tied to its role as a major pharmaceutical exporter, supported by legislation that prevents ‘patent evergreening’ and enables generic drug manufacturing, says a study by diabetologists
This is a source-based summary, not original reporting by Ebenezer journalists. Source: The Hindu. Ebenezer published 19 Sept 2026, 04:23 pm. Editorial policy.
Read the original report on The Hindu →
India — The Hindu


